Skip to main content

Table 4 Mean ± SD number of short, medium, and long convulsions following the intraperitoneal administration of bupropion HCl and bupropion metabolites

From: Convulsive liability of bupropion hydrochloride metabolites in Swiss albino mice

Dose* (mg/kg)

Bupropion HCl

Erythrohydrobupropion HCl

Threohydrobupropion HCl

Hydroxybupropion HCl

 

Short (0–10 s)

Medium (11–30 s)

Long (≥ 31 s)

Short (0–10 s)

Medium (11–30 s)

Long (≥ 31 s)

Short (0–10 s)

Medium (11–30 s)

Long (≥ 31 s)

Short (0–10 s)

Medium (11–30 s)

Long (≥ 31 s)

25

-

-

-

-

-

-

-

-

-

-

-

-

50

-

-

-

0.1 ± 0.3

-

-

6.6 ± 8.9

0.3 ± 0.5

0.1 ± 0.3

7.9 ± 8.3

1.6 ± 2.6

1.5 ± 1.6

75

0.5 ± 1.6

-

-

4.4 ± 6.0

0.6 ± 1.0

0.5 ± 0.5

13.2 ± 9.7

5.5 ± 6.6

2.5 ± 2.3

136.1 ± 108.2

8.0 ± 7.2

3.4 ± 3.3

  1. *10 mice per dose per treatment.
  2. - Indicates no convulsions.